General Information of the Compound
Compound ID |
CP0036204
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
CAS_36322-90-4
Show/Hide
|
||||||||||||||||||
Synonyms |
(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1
4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German]
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
AK1015
Akten
Apo-Piroxicam
Artroxicam
Brexidol (TN)
Brexin (TN)
Bruxicam
CHF 1251
CP 16171
CP-16171
CP16171
Caliment
Erazon
Erazon (TN)
Exipan (TN)
Felden
Felden (TN)
Feldene
Feldene (TN)
Feldene Fast
Feldene Gel
Feldene, Roxam, Piroxicam
Feldoral (TN)
Flogobene
Geldene
Hotemin (TN)
Improntal
Larapam
Mobilis (TN)
P 5654
Pipoxicam
Pirkam
Piroflex
Piroftal
Pirox von ct (TN)
Piroxicam
Piroxicam (JP15/USP/INN)
Piroxicam [USAN:BAN:INN:JAN]
Piroxicam usp
Piroxicamum
Piroxicamum [INN-Latin]
Proponol (TN)
Pyroxycam
Reudene
Reumador (TN)
Riacen
Roxicam
Roxiden
Sasulen
Solocalm
Tracam (TN)
Veral (TN)
Vurdon (TN)
Zunden
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H13N3O4S
|
||||||||||||||||||
Molecular Weight |
331.353
|
||||||||||||||||||
Canonical SMILES |
CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)
Show/Hide
|
||||||||||||||||||
InChIKey |
QYSPLQLAKJAUJT-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
36322-90-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02209, Organic anion transporter 3
Protein ID: PT04064, Solute carrier family 22 member 6
Clinical Information about the Compound